Topic: BRISTOL MYERS SQUIBB
55 results were found.
BioArctic in agreement with Bristol Myers Squibb for its PyroGlutamate-amyloid-beta antibody program - December 20, 2024
Bristol Myers Squibb Q4 revenues $11.5 billion - February 3, 2024
Bristol Myers Squibb to acquire Karuna Therapeutics for $14bn - December 29, 2023
Bristol Myers Squibb will acquire RayzeBio for $4.1 billion - December 26, 2023
Bristol Myers Squibb acquires Mirati Therapeutics for $4.8b - October 9, 2023
Bristol Myers Squibb Q1 revenues $11.3 billion - April 28, 2023
Bristol Myers Squibb Q4 revenues $11.4 billion - February 3, 2023
Bristol Myers Squibb Q3 revenues $11.2 billion - October 26, 2022
Bristol Myers Squibb buys Turning Point Therapeutics - June 4, 2022
Bristol Myers Squibb Q4 revenues $12.0 billion - February 5, 2022
WuXi STA completes acquisition of Bristol Myers Squibb facility in Switzerland - August 3, 2021
Bristol Myers Squibb Q2 revenues up 16% - July 29, 2021
Kentucky joins DOJ, multi-state coalition in $75m settlement with Bristol-Myers Squibb for overcharging Medicaid - July 15, 2021
Bristol Myers Squibb to pay $1.6 billion for new cancer drug - May 18, 2021
New Mexico: Lawsuit filled against Gilead, Bristol-Myers Squibb, Teva in HIV/AIDS drugs case - March 4, 2021
Hawaii AG: Bristol Myers Squibb and Sanofi ordered to pay $834m in Plavix case - February 19, 2021
Bristol Myers Squibb to acquire MyoKardia for $13.1 billion in cash - October 5, 2020
Bristol Myers Squibb enters agreement to acquire Forbius - August 24, 2020
Bristol-Myers Squibb Q1 revenues increased 82 percent - May 7, 2020
Bristol-Myers Squibb completes divestment of manufacturing facility in Anagni, Italy - January 7, 2020
Bristol-Myers Squibb completes acquisition of Celgene - November 21, 2019
Bristol-Myers Squibb must sell psoriasis drug to buy Celgene - November 16, 2019
Bristol-Myers Squibb to sell Otezla before merger with Celgene - June 25, 2019
FTC seeks more information about Bristol-Myers Squibb-Celgene's $74 billion merger - March 26, 2019
Bristol-Myers Squibb says Celgene takeover is good move - March 6, 2019
Bristol-Myers Squibb turns to profit - January 24, 2019
Bristol-Myers Squibb to buy Celgene, it sinks, Celgene jumps - January 3, 2019
Bristol-Myers Squibb Q2 revenues increased 11% - July 26, 2018
Russian court dismisses Bristol-Myers Squibb lawsuit over medicine production - June 28, 2018
Bristol-Myers Squibb to pay $1.85 billion in cancer deal with Nektar - February 15, 2018
Bristol-Myers Squibb posts increase in Q4 earnings - February 5, 2018
Bristol-Myers Squibb appoints Saurabh Saha as SVP - October 10, 2017
Bristol-Myers Squibb appoints Karen Vousden to board - September 15, 2017
Bristol-Myers Squibb to acquire IFM Therapeutics for $300+ million - August 5, 2017
Bristol-Myers Squibb appoints Thomas J. Lynch, Jr. as EVP - March 9, 2017
Bristol-Myers Squibb appoints Giovanni Caforio as chairman - December 22, 2016
Bristol-Myers Squibb appoints oncology development head - July 27, 2016
Bristol-Myers Squibb buys Cormorant Pharma in $520 million deal - July 5, 2016
Bristol-Myers Squibb: Murdo Gordon EVP and chief commercial officer - June 22, 2016
Bristol-Myers Squibb appoints Peter J. Arduini to board - March 7, 2016
GSK’s ViiV Healthcare to acquire Bristol-Myers Squibb’s R&D HIV assets - December 18, 2015
Bristol-Myers Squibb Q3 revenues $4.1 billion - October 27, 2015
Bristol-Myers Squibb names SVP, head of business development - October 16, 2015
SEC charges Bristol-Myers Squibb, company will pay $14 million - October 5, 2015
Bristol-Myers Squibb to acquire Promedior for up to $1.25 billion - August 31, 2015
Bristol-Myers Squibb to open one new site, close two - June 25, 2015
Bristol-Myers Squibb to use uniQure's gene therapy - April 8, 2015
Bristol-Myers Squibb appoints Giovanni Caforio CEO - January 22, 2015
Bristol-Myers Squibb names Giovanni Caforio COO and to board - June 10, 2014
Bristol-Myers Squibb: Francis Cuss EVP, Elliott Sigal to retire - April 8, 2013
Bristol-Myers Squibb appoints SVP, human resources - February 15, 2013
Bristol-Myers Squibb appoints Frances Heller SVP, business development - October 1, 2012
Bristol-Myers Squibb elected chief financial officer - April 14, 2010
Bristol-Myers Squibb names new CEO - March 3, 2010
Bristol-Myers Squibb: Jean-Marc Huet to leave, Charles Bancroft acting CFO - December 18, 2009